rivastigmine

(redirected from Rivastigmine tartrate)
Also found in: Medical.
Related to Rivastigmine tartrate: Fenofibrate, Exelon

riv·a·stig·mine

 (rĭv′ə-stĭg′mēn′)
n.
A drug, C14H22N2O2, that inhibits the action of cholinesterase and is used to treat dementia in people with Alzheimer's disease and Parkinson's disease.

[riva-, of unknown origin + (physo)stigmine.]
Translations

rivastigmine

n rivastigmina
References in periodicals archive ?
Aurobindo also received final approval for rivastigmine tartrate capsules USP, 1.
Karlsruhe, Germany), 120 mg and matching rivastigmine tartrate (Exelon, Novartis Pharms co.
Reddya[euro](tm)s Laboratories unveils Rivastigmine tartrate capsules in the US market(C)2011 M2 COMMUNICATIONS http://www.
Reddy's launches Rivastigmine Tartrate Capsules(C)2011 M2 COMMUNICATIONS
The research shows that patients taking the Alzheimer's drug rivastigmine tartrate had significantly fewer dementia symptoms than those given a dummy placebo treatment.
Aurobindo Pharma is in receipt of final approval from the US Food & Drug Administration (USFDA) for production and marketing of Rivastigmine Tartrate Capsules USP, 1.
In 2012 the company launched Rivastigmine Tartrate capsules, a generic version of Exelon by Novartis, after settling its Paragraph IV patent litigation, as well as Nevirapine tablets, a first-to-market generic version of Viramune by Boehringer Ingelheim, and Methscopolamine tablets, a generic version of Pamine and Pamiue Forte by Kenwood Therapeutics.
Other products Sandoz has launched this year include naratriptan hydrochloride tablets (Amerge by GlaxoSmithKline), rivastigmine tartrate capsules (Exelon by Novartis Pharmaceuticals Corp.